Uninvest

Uninvest is a venture capital firm founded in 2005 and headquartered in Santiago de Compostela, Spain. The firm specializes in managing technology transfer funds and focuses on investing in sectors such as nanotechnology, new materials, agri-food, biotechnology, and medical technology. Uninvest primarily targets companies located within the Spanish region, aiming to support innovation and development in these key areas.

Jaime De Rábago

Venture Partner

Fermin Goytisolo Ph.D

Partner

9 past transactions

Grant

Series A in 2021
Grant offers Banking for SaaS (Software as a Service) companies. Banking for Saas companies can be different from traditional banking for businesses because of the unique nature of SaaS businesses because SaaS companies operate in a fast-paced, agile environment with rapidly changing revenue streams, customer bases, and operational costs.

NANOGAP

Venture Round in 2014
Nanogap is a nanomaterials company that specializes in the production and commercialization of innovative nanoparticle materials. Founded in 2006 and headquartered in A Coruña, the company utilizes a proprietary wet chemistry technology to create Atomic Quantum Clusters and other advanced materials, including spherical nanoparticles, high aspect ratio nanofibers, Charge Transfer Clusters, and Charge Transfer Cluster Nanosomes. These products exhibit a range of beneficial properties, enabling applications in conductive inks, antistatic coatings, transparent conductive films, and photoluminescent materials for security printing. Additionally, Nanogap's offerings include antimicrobial additives for various surfaces and potential therapeutic treatments for cancer. The company adopts a flexible business model that allows for custom product development, product sales, and licensing agreements, catering to diverse customer needs across multiple industries.

Genmedica Therapeutics

Venture Round in 2011
Genmedica Therapeutics, S.L. is a clinical-stage biopharmaceutical company based in Barcelona, Spain, specializing in the research and development of innovative treatments for type 2 diabetes. Founded in 2004, the company is focused on creating orally available new chemical entities (NCEs), including its lead compounds, GMC-252 and GMC-316, which aim to effectively lower glycemia while also modifying the disease's progression. Additionally, Genmedica is advancing the GMC-278 drug discovery program to identify new molecules that target both type 2 diabetes and obesity. By leveraging its proprietary OSIF platform, the company seeks to develop dual-action small molecules that address oxidative stress and inflammation, ultimately improving the quality of life for diabetic patients.

Indizen Optical Technologies

Venture Round in 2008
Indizen Optical Technologies is a Madrid-based company that specializes in the development of ophthalmic products, particularly focusing on contact lens design software. The company engages in optical research and development, providing a range of services that include business consulting, technical consulting, technical audits, technical support, and marketing services. Through its innovative approach, Indizen aims to advance the field of optical technology and enhance the effectiveness of ophthalmic solutions.

ERA Biotech

Venture Round in 2008
ERA Biotech specializes in the development and implementation of advanced cell-based biomanufacturing technologies. The company utilizes its proprietary tools, Zera and StorPro, to enhance performance in standard eukaryotic culture systems, which are widely used for the production of protein drugs, enzymes, and other biological products. Additionally, ERA Biotech focuses on biotechnology research, leveraging its technologies to create innovative solutions for existing enzymes and novel recombinant and plasmid DNA vaccines. The firm aims to deliver significant advancements in protein-cleavage and purification systems, positioning itself as a key player in the biotechnology sector.

Agrasys

Seed Round in 2008
Agrasys S.L. is a technology-driven agrifood company based in Barcelona, Spain, focused on developing and commercializing innovative crop varieties through plant breeding and biotechnology. Established in 2005 as a spin-off of the Spanish High Council for Scientific Investigations, Agrasys specializes in Tritordeum, a cereal created by hybridizing durum wheat with a wild barley species, and Triticale, a hybrid of wheat and rye. The company aims to enhance agronomic and nutritional advantages in the food industry, contributing to sectors such as natural functional foods and biofuels. Agrasys actively engages in research and development collaborations with public research centers and independent companies and has secured financial support from various national and European institutions to further its projects.

Teikhos Tech

Series A in 2007
Teikhos Tech, S.L. develops, designs, manufactures, and commercializes software technology for the fashion and clothing sector. The software integrates pattern-making, fashion design, realistic weave simulation, catwalk, fitting room, and an online store. It offers designers the necessary tools for the development of their ideas, such as drawing sketches, revising changes or fabric combination, and allowing them to visualize the results of the designs on realistic simulations on virtual moving mannequins. The company serves small fashion and clothing companies, as well as training centers and designers.

ERA Biotech

Convertible Note in 2006
ERA Biotech specializes in the development and implementation of advanced cell-based biomanufacturing technologies. The company utilizes its proprietary tools, Zera and StorPro, to enhance performance in standard eukaryotic culture systems, which are widely used for the production of protein drugs, enzymes, and other biological products. Additionally, ERA Biotech focuses on biotechnology research, leveraging its technologies to create innovative solutions for existing enzymes and novel recombinant and plasmid DNA vaccines. The firm aims to deliver significant advancements in protein-cleavage and purification systems, positioning itself as a key player in the biotechnology sector.

Vigilante

Series B in 2001
Vigilante family of plumbers has been serving Brooklyn for over 80 Years with superior plumbing repairs and heating maintenance. As a family owned business, they recognize the importance of providing the old‐fashioned, personalized service similar to that of yester‐year. At Vigilante, you're not just another customer, you're a valued part of their success. Their employees are trained to provide great customer service. Since 1927, New York families have trusted their tried and true reputation of serving the community with complete, efficient, and cost‐effective plumbing and heating services. With a highly trained and tested staff of plumbing and heating technicians equipped with the most advanced tools to date
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.